Farmers from across the UK descended on central London yesterday to demonstrate against Rachel Reeves's plans on controversial UK inheritance tax reforms.

Millions of Brits will be holding their breath to see how the hotly anticipated Budget will impact their wallets and whether Reeves can plug the blackhole in public finances ...

Agriculturists were banned from bringing their tractors amid protest plans against controversial UK inheritance tax reforms, known as 'family farm tax' ahead of Rachel Reeves' Budget, ...

Gretta Viola Crosby Abbott was born March 6, 1934 and grew up in and around Savannah. She was a graduate of Commercial High School and had a post-child-rearing career at Coastal Bank, from which she ...

Abbott Laboratories ABT-1.10%decrease; red down pointing triangle agreed to acquire cancer diagnostics company Exact Sciences EXAS 0.04%increase; green up pointing triangle in a deal valued at about ...

Abbott to buy Exact Sciences in $23 billion deal Exact's flagship colorectal cancer test to join Abbott's portfolio Abbott eyes international expansion for Exact's tests Aims for broad reimbursement ...

North suburban-based Abbott Laboratories announced a $21 billion deal Thursday morning to acquire Exact Sciences, the maker of Cologuard — its largest acquisition in a decade. The deal will allow ...

Abbott Laboratories could be looking to acquire Exact Sciences, according to a report from Bloomberg, citing people close to the deal. News of the rumored deal caused Madison, WI-based Exact Sciences ...

Forbes contributors publish independent expert analyses and insights. Bruce Japsen writes about healthcare business and policy. Abbott Laboratories $21 billion deal to acquire cancer test maker Exact ...

Abbott announced on Thursday, Nov. 20 it plans to buy Exact Sciences, a Madison-based maker of cancer screening and diagnostic tests, in a deal valued at an estimated $23 billion, including debt. The ...

Exact Sciences Corporation stock surged after Abbott Laboratories announces a $21bn acquisition at $105 per share, driven by Exact's cancer diagnostics leadership. Exact Sciences boasts strong revenue ...

Shares of Exact Sciences (EXAS) continued to rise in the premarket on Thursday, adding ~18% after the cancer test maker agreed to be acquired by Abbott Laboratories (ABT) in an all-cash deal worth ...